<prompt> Please answer with one of the option in the bracket. Write reasoning in between . Write answer in between .Q:A 37-year-old patient is being evaluated for involuntary movements, difficulty swallowing food, and personality change. He has entered a clinical trial that is studying the interaction of certain neuromediators in patients with similar CAG n trinucleotide repeat disorders. The laboratory results of 1 of the candidates for the clinical trial are presented below:Acetylcholine Dopamine Gamma-aminobutyric acid GABA Norepinephrine unchangedSerotonin unchangedWhich trinucleotide disorder most likely represents the diagnosis of this patient?? A: Myotonic dystrophy, B: Friedreichs ataxia, C: Fragile X syndrome, D: Huntingtons disease, E: Spinobulbar muscular atrophy,  <response>: This is a clinical case about a 37-year-old patient with involuntary movements, difficulty swallowing, and personality changes. The question asks which trinucleotide repeat disorder is most likely the diagnosis based on neuromediator findings. The key finding is decreased acetylcholine, increased dopamine, and decreased GABA. This neuromediator pattern is most consistent with Huntingtons disease, which is caused by expanded CAG repeats. Myotonic dystrophy, Friedreichs ataxia, Fragile X syndrome, and spinobulbar muscular atrophy would not have this exact neuromediator profile.D: Huntingtons disease 